Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy-Reference-Cited by-同舟云学术

Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy

Published:2024-02 Issue:2 Volume:118 Page:404-414
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Simone Charles B.^ORCID,Serebrenik Artur A.^ORCID,Gore Elizabeth M.,Mohindra Pranshu,Brown Stephen L.,Wang Ding,Chetty Indrin J.,Vujaskovic Zeljko,Menon Smitha,Thompson Jonathan,Fine Gil,Kaytor Michael D.,Movsas Benjamin

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference39 articles.

1. National Cancer Institute. Surveillance, Epidemiology and End Results Program. Available at: www.seer.cancer.gov. Accessed December 26, 2022.

2. Cancer treatment and survivorship statistics, 2016;Miller;CA Cancer J Clin,2016

3. Outcomes of chemoradiation for patients with locally advanced non-small-cell lung cancer;Spina;Intern Med J,2013

4. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis;Palma;Int J Radiat Oncol Biol Phys,2013

5. Thoracic radiation normal tissue injury;Simone;Semin Radiat Oncol,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BIO 300: A Prophylactic Radiation Countermeasure for Acute Radiation Syndrome;Military Medicine;2024-08-19

2. BIO 300 Attenuates Whole Blood Transcriptome Changes in Mice Exposed to Total-Body Radiation;International Journal of Molecular Sciences;2024-08-13

3. Erratum to: Simone CB 2nd, Serebrenik AA, Gore EM, et al. Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy. Int J Radiat Oncol Biol Phys 2023;118(2):404-414.;International Journal of Radiation Oncology*Biology*Physics;2024-07

4. Genistein: A promising phytoconstituent with reference to its bioactivities;Phytotherapy Research;2024-06-03

5. Role of natural products in tumor therapy from basic research and clinical perspectives;Acta Materia Medica;2024